Who are Kindbiotechnology's investors?

Kindbiotechnology's investors include Draper Associates, Future Ventures.

Kindbiotechnology

2 known investors

Kind Biotechnology develops the ION platform, which uses artificial genomic constructs to grow interconnected peripheral organs for xenotransplantation. The company aims to address organ scarcity in transplant medicine to treat age-related organ failure and extend healthy human lifespan.

Biotech Longevity Medical Devices

Investors · 2

Draper AssociatesSan Mateo · $500K – $5M

Future VenturesLos Altos · $1M – $10M

Competitors · 1

by search overlap

K2 Biolabs3 shared keywordsK2bio is a contract research organization offering in vivo study design, execution, and analysis in an AAALAC-accredited vivarium, along with in vitro research and pharmacology services for biotech and pharmaceutical partners. It also provides private lab spaces, benches, and scientific infrastructure for research teams in Houston's biotech hub.

Companies competing with Kindbiotechnology for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Kindbiotechnology do?: Kind Biotechnology develops the ION platform, which uses artificial genomic constructs to grow interconnected peripheral organs for xenotransplantation. The company aims to address organ scarcity in transplant medicine to treat age-related organ failure and extend healthy human lifespan.
Who are Kindbiotechnology's investors?: Kindbiotechnology's investors include Draper Associates, Future Ventures.